Lethal Mutagenesis of Poliovirus Mediated by a Mutagenic Pyrimidine Analogue
暂无分享,去创建一个
Blake R. Peterson | David Loakes | C. Cameron | A. Paul | E. Smidansky | B. Peterson | David Franco | V. S. Korneeva | Jason D Graci | D. Loakes | Daniel M. Brown | Jason D. Graci | Daniel A. Harki | Victoria S. Korneeva | Jocelyn P. Edathil | Kathleen Too | David Franco | Eric D. Smidansky | Aniko V. Paul | Craig E. Cameron | Kathleen Too
[1] C. Ofria,et al. Evolution of digital organisms at high mutation rates leads to survival of the flattest , 2001, Nature.
[2] H. Adams,et al. The effect of tautomeric constant on the specificity of nucleotide incorporation during DNA replication: support for the rare tautomer hypothesis of substitution mutagenesis. , 2003, Journal of molecular biology.
[3] Ron B. H. Wills,et al. Effects of temperature. , 2007 .
[4] C. Cameron,et al. Synthesis and antiviral evaluation of a mutagenic and non-hydrogen bonding ribonucleoside analogue: 1-beta-D-Ribofuranosyl-3-nitropyrrole. , 2002, Biochemistry.
[5] E. Domingo,et al. Suppression of viral infectivity through lethal defection. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[6] E. Domingo,et al. The quasispecies (extremely heterogeneous) nature of viral RNA genome populations: biological relevance--a review. , 1985, Gene.
[7] E. Domingo,et al. Curing of foot-and-mouth disease virus from persistently infected cells by ribavirin involves enhanced mutagenesis. , 2003, Virology.
[8] J. Arnold,et al. Poliovirus RNA-dependent RNA polymerase (3Dpol): pre-steady-state kinetic analysis of ribonucleotide incorporation in the presence of Mg2+. , 2004, Biochemistry.
[9] R. Lanford,et al. Ribavirin Induces Error-Prone Replication of GB Virus B in Primary Tamarin Hepatocytes , 2001, Journal of Virology.
[10] C. Wagner,et al. Pronucleotides: Toward the in vivo delivery of antiviral and anticancer nucleotides , 2000, Medicinal research reviews.
[11] D. Santi,et al. High-pressure liquid chromatography--ultraviolet analysis of intracellular nucleotides. , 1982, Analytical biochemistry.
[12] M. Huynen,et al. Neutral evolution of mutational robustness. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[13] E. Domingo,et al. Lethal mutagenesis of the prototypic arenavirus lymphocytic choriomeningitis virus (LCMV). , 2003, Virology.
[14] E. Domingo,et al. Mutagenesis versus Inhibition in the Efficiency of Extinction of Foot-and-Mouth Disease Virus , 2003, Journal of Virology.
[15] Edward C. Holmes,et al. Is the Quasispecies Concept Relevant to RNA Viruses? , 2002, Journal of Virology.
[16] M. Vignuzzi,et al. Quasispecies diversity determines pathogenesis through cooperative interactions in a viral population , 2006, Nature.
[17] Synthesis and RNA polymerase incorporation of the degenerate ribonucleotide analogue rPTP. , 1998, Nucleic acids research.
[18] P. Crain,et al. Preparation and enzymatic hydrolysis of DNA and RNA for mass spectrometry. , 1990, Methods in enzymology.
[19] Julie K. Pfeiffer,et al. A single mutation in poliovirus RNA-dependent RNA polymerase confers resistance to mutagenic nucleotide analogs via increased fidelity , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[20] Deborah Chavez,et al. Antiviral Effect and Virus-Host Interactions in Response to Alpha Interferon, Gamma Interferon, Poly(I)-Poly(C), Tumor Necrosis Factor Alpha, and Ribavirin in Hepatitis C Virus Subgenomic Replicons , 2003, Journal of Virology.
[21] E. Holmes,et al. Evidence for the non-quasispecies evolution of RNA viruses [corrected]. , 2001, Molecular biology and evolution.
[22] D. Smee,et al. Error-prone replication of West Nile virus caused by ribavirin. , 2005, Antiviral research.
[23] M. Vignuzzi,et al. Remote Site Control of an Active Site Fidelity Checkpoint in a Viral RNA-dependent RNA Polymerase* , 2005, Journal of Biological Chemistry.
[24] C. Cameron,et al. Synthesis of a Universal 5‐Nitroindole Ribonucleotide and Incorporation into RNA by a Viral RNA‐Dependent RNA Polymerase , 2007, Chembiochem : a European journal of chemical biology.
[25] D. M. Brown,et al. The mechanism of mutation induction by a hydrogen bond ambivalent, bicyclic N4-oxy-2'-deoxycytidine in Escherichia coli. , 1997, Nucleic acids research.
[26] J. Arnold,et al. Poliovirus RNA-dependent RNA polymerase (3D(pol)). Assembly of stable, elongation-competent complexes by using a symmetrical primer-template substrate (sym/sub). , 2000, The Journal of biological chemistry.
[27] E. Wimmer,et al. Mouse neurovirulence determinants of poliovirus type 1 strain LS-a map to the coding regions of capsid protein VP1 and proteinase 2Apro , 1994, Journal of virology.
[28] A. Karlsson,et al. Substrate specificity and phosphorylation of antiviral and anticancer nucleoside analogues by human deoxyribonucleoside kinases and ribonucleoside kinases , 2003, Pharmacology & Therapeutics.
[29] G. Folkers,et al. Substrate Diversity of Herpes Simplex Virus Thymidine Kinase , 1999, The Journal of Biological Chemistry.
[30] S. Elena,et al. The evolution of RNA viruses: A population genetics view. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[31] C. Cameron,et al. Mechanisms of action of ribavirin against distinct viruses , 2005, Reviews in medical virology.
[32] Thomas J. Wisniewski,et al. Production of "authentic" poliovirus RNA-dependent RNA polymerase (3D(pol)) by ubiquitin-protease-mediated cleavage in Escherichia coli. , 1999, Protein expression and purification.
[33] D. M. Brown,et al. Molecular basis for methoxyamine initiated mutagenesis. 1H nuclear magnetic resonance studies of base-modified oligodeoxynucleotides. , 1991, Journal of molecular biology.
[34] J. Arnold,et al. The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen , 2000, Nature Medicine.
[35] E. Wimmer,et al. Brefeldin A Inhibits Cell-Free, De Novo Synthesis of Poliovirus , 1998, Journal of Virology.
[36] David A. Steinhauer,et al. Mutation Frequencies at Defined Single Codon Sites in Vesicular Stomatitis Virus and Poliovirus Can Be Increased Only Slightly by Chemical Mutagenesis , 1990, Journal of virology.
[37] C. Otsuka,et al. HIGHLY EFFICIENT RANDOM MUTAGENESIS IN TRANSCRIPTION-REVERSE-TRANSCRIPTION CYCLES BY A HYDROGEN BOND AMBIVALENT NUCLEOSIDE 5′-TRIPHOSPHATE ANALOGUE: POTENTIAL CANDIDATES FOR A SELECTIVE ANTI-RETROVIRAL THERAPY , 2001, Nucleosides, nucleotides & nucleic acids.
[38] C. Cameron,et al. Synthesis and antiviral activity of 5-substituted cytidine analogues: identification of a potent inhibitor of viral RNA-dependent RNA polymerases. , 2006, Journal of medicinal chemistry.
[39] E. Domingo,et al. Efficient Virus Extinction by Combinations of a Mutagen and Antiviral Inhibitors , 2001, Journal of Virology.
[40] S. Elena,et al. Basic concepts in RNA virus evolution , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[41] Tetsuya Suzuki,et al. Template properties of mutagenic cytosine analogues in reverse transcription , 2006, Nucleic acids research.
[42] D. M. Brown,et al. Polymerase recognition of synthetic oligodeoxyribonucleotides incorporating degenerate pyrimidine and purine bases. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[43] A. Paul,et al. Cell-free, de novo synthesis of poliovirus. , 1991, Science.
[44] Xin Yao,et al. Evolutionary Optimization , 2002 .
[45] P. Schuster,et al. Stationary mutant distributions and evolutionary optimization. , 1988, Bulletin of mathematical biology.
[46] E. Wimmer,et al. The C-terminal residues of poliovirus proteinase 2A(pro) are critical for viral RNA replication but not for cis- or trans-proteolytic cleavage. , 2001, The Journal of general virology.
[47] Rong Liu,et al. The effect of ribavirin and IMPDH inhibitors on hepatitis C virus subgenomic replicon RNA. , 2003, Virology.
[48] William E. Severson,et al. Ribavirin Causes Error Catastrophe during Hantaan Virus Replication , 2003, Journal of Virology.
[49] J. Mullins,et al. Lethal mutagenesis of HIV with mutagenic nucleoside analogs. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[50] R. Andino,et al. Poliovirus Requires a Precise 5′ End for Efficient Positive-Strand RNA Synthesis , 2000, Journal of Virology.
[51] B. Hurlburt,et al. Conservative mutations of glutamine-125 in herpes simplex virus type 1 thymidine kinase result in a ganciclovir kinase with minimal deoxypyrimidine kinase activities. , 2000, Biochemistry.
[52] C. Cameron,et al. Challenges for the Development of Ribonucleoside Analogues as Inducers of Error Catastrophe , 2004, Antiviral chemistry & chemotherapy.
[53] E. Wimmer,et al. Effects of temperature and lipophilic agents on poliovirus formation and RNA synthesis in a cell-free system , 1993, Journal of virology.
[54] Claus O Wilke,et al. Quasispecies theory in the context of population genetics , 2005, BMC Evolutionary Biology.
[55] M. Anikin,et al. Characterization of T7 RNA Polymerase Transcription Complexes Assembled on Nucleic Acid Scaffolds* , 2002, The Journal of Biological Chemistry.
[56] Pedro R. Lowenstein,et al. Response of Foot-and-Mouth Disease Virus to Increased Mutagenesis: Influence of Viral Load and Fitness in Loss of Infectivity , 2000, Journal of Virology.
[57] K. Anderson,et al. Mechanism of action of a novel viral mutagenic covert nucleotide: molecular interactions with HIV-1 reverse transcriptase and host cell DNA polymerases. , 2005, Antiviral research.
[58] E. Domingo,et al. Lack of evidence for proofreading mechanisms associated with an RNA virus polymerase. , 1992, Gene.
[59] E. Domingo,et al. Quasispecies Theory in Virology , 2002, Journal of Virology.
[60] C. Cameron,et al. RNA virus error catastrophe: Direct molecular test by using ribavirin , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[61] M. Moyer,et al. Lack of bystander killing in herpes simplex virus thymidine kinase-transduced colon cell lines due to deficient connexin43 gap junction formation. , 1998, Human gene therapy.